http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2423127-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d96cb4c783c768fd075736cbfefc3b3b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
filingDate 2006-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce8eab5c38db9d9a2546b0598161128d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a4af40c50f09038cc4d218c3510f45f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b68e84c81a8c63a7bab074c3588b0fc
publicationDate 2011-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2423127-C2
titleOfInvention Therapeutic medication against corneal-conjunctival disturbance
abstract FIELD: medicine. n SUBSTANCE: invention relates to field of medicine, in particular, to ophthalmology. Therapeutic medication for treatment of corneal-conjunctival disturbance contains eprosartan or its salt as active ingredient. Medication is made in dosed form, which is applied by introduction to patient during treatment in form of eye drops or ophthalmic ointment. n EFFECT: invention ensures treatment of such disturbances as dry eye syndrome, ulcer of cornea, keratitis, conjunctivitis, punctuate superficial keratitis, disturbances of corneal epithelium, dry keratoconjunctivitis, upper limbic keratoconjunctivitis or filamentary keratitis. n 9 cl, 1 tbl, 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-4412-C1
priorityDate 2005-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448475406
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448475405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425188129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50989844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45266664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281037

Total number of triples: 36.